vs
LANDS' END, INC.（LE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是LANDS' END, INC.的2.0倍（$622.0M vs $317.5M），Royalty Pharma plc净利率更高（34.4% vs 1.6%，领先32.8%），Royalty Pharma plc同比增速更快（4.8% vs 0.1%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.9%）
Lands' End是1963年诞生于美国芝加哥的服饰零售品牌，最初以邮购游艇用品起家，目前业务拓展至服饰、箱包与家居用品领域。截至2024年2月，品牌在美国本土共开设26家门店，总部位于威斯康星州道奇维尔。品牌名源自地名兰兹角，因创立时印刷错了撇号位置又无力重印，错拼的名称便沿用至今。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LE vs RPRX — 直观对比
营收规模更大
RPRX
是对方的2.0倍
$317.5M
营收增速更快
RPRX
高出4.7%
0.1%
净利率更高
RPRX
高出32.8%
1.6%
两年增速更快
RPRX
近两年复合增速
-0.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $317.5M | $622.0M |
| 净利润 | $5.2M | $214.2M |
| 毛利率 | 51.8% | — |
| 营业利润率 | 5.3% | 62.4% |
| 净利率 | 1.6% | 34.4% |
| 营收同比 | 0.1% | 4.8% |
| 净利润同比 | 198.3% | 2.9% |
| 每股收益（稀释后） | $0.17 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LERPRX
| Q4 25 | $317.5M | $622.0M | ||
| Q3 25 | — | $609.3M | ||
| Q2 25 | $261.2M | $578.7M | ||
| Q1 25 | — | $568.2M | ||
| Q4 24 | $318.6M | $593.6M | ||
| Q3 24 | $317.2M | $564.7M | ||
| Q2 24 | $285.5M | $537.3M | ||
| Q1 24 | $514.9M | $568.0M |
净利润LERPRX
| Q4 25 | $5.2M | $214.2M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | $-8.3M | $30.2M | ||
| Q1 25 | — | $238.3M | ||
| Q4 24 | $-593.0K | $208.2M | ||
| Q3 24 | $-5.3M | $544.0M | ||
| Q2 24 | $-6.4M | $102.0M | ||
| Q1 24 | $-8.6M | $4.8M |
毛利率LERPRX
| Q4 25 | 51.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 50.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 50.6% | — | ||
| Q3 24 | 47.9% | — | ||
| Q2 24 | 48.7% | — | ||
| Q1 24 | 38.0% | — |
营业利润率LERPRX
| Q4 25 | 5.3% | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | -0.9% | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | 2.9% | 60.9% | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.8% | 50.2% | ||
| Q1 24 | 1.6% | -13.0% |
净利率LERPRX
| Q4 25 | 1.6% | 34.4% | ||
| Q3 25 | — | 47.3% | ||
| Q2 25 | -3.2% | 5.2% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | -0.2% | 35.1% | ||
| Q3 24 | -1.7% | 96.3% | ||
| Q2 24 | -2.3% | 19.0% | ||
| Q1 24 | -1.7% | 0.8% |
每股收益（稀释后）LERPRX
| Q4 25 | $0.17 | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | $-0.27 | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | $-0.02 | $0.46 | ||
| Q3 24 | $-0.17 | $1.21 | ||
| Q2 24 | $-0.20 | $0.23 | ||
| Q1 24 | $-0.27 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.3M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $231.0M | $9.7B |
| 总资产 | $852.7M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资LERPRX
| Q4 25 | $36.3M | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | $18.1M | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $30.4M | $929.0M | ||
| Q3 24 | $25.6M | $950.1M | ||
| Q2 24 | $27.4M | $1.8B | ||
| Q1 24 | $25.3M | $843.0M |
总债务LERPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益LERPRX
| Q4 25 | $231.0M | $9.7B | ||
| Q3 25 | — | $9.6B | ||
| Q2 25 | $230.1M | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $223.6M | $10.3B | ||
| Q3 24 | $226.5M | $10.3B | ||
| Q2 24 | $234.6M | $9.8B | ||
| Q1 24 | $241.6M | $9.9B |
总资产LERPRX
| Q4 25 | $852.7M | $19.6B | ||
| Q3 25 | — | $19.3B | ||
| Q2 25 | $760.5M | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | $843.6M | $18.2B | ||
| Q3 24 | $802.5M | $18.0B | ||
| Q2 24 | $800.1M | $17.7B | ||
| Q1 24 | $811.5M | $16.1B |
负债/权益比LERPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-22.4M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | -3.03× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-55.0M | — |
8季度趋势，按日历期对齐
经营现金流LERPRX
| Q4 25 | $-15.7M | $827.1M | ||
| Q3 25 | — | $702.6M | ||
| Q2 25 | $-22.5M | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $-17.1M | $742.5M | ||
| Q3 24 | $30.7M | $703.6M | ||
| Q2 24 | $-25.8M | $658.2M | ||
| Q1 24 | $93.9M | $664.6M |
自由现金流LERPRX
| Q4 25 | $-22.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-30.7M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-27.8M | — | ||
| Q3 24 | $26.0M | — | ||
| Q2 24 | $-32.6M | — | ||
| Q1 24 | $87.5M | — |
自由现金流率LERPRX
| Q4 25 | -7.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -11.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.7% | — | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | -11.4% | — | ||
| Q1 24 | 17.0% | — |
资本支出强度LERPRX
| Q4 25 | 2.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 1.2% | — |
现金转化率LERPRX
| Q4 25 | -3.03× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LE
| U Se Commerce | $179.8M | 57% |
| Business Outfitters Revenue | $78.8M | 25% |
| Licensing And Retail | $20.2M | 6% |
| Other | $19.8M | 6% |
| Third Party | $18.9M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
